Nektar Therapeutics (NKTR) Interest Coverage Ratio (QoQ) (2010 - 2026)
Nektar Therapeutics (NKTR) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.64% |
| Dec 31, 2025 | 45.93% |
| Sep 30, 2025 | 22.02% |
| Jun 30, 2025 | 24.98% |
| Mar 31, 2025 | -733.58% |
| Dec 31, 2024 | 124.77% |
| Sep 30, 2024 | 26.55% |
| Jun 30, 2024 | -21.27% |
| Mar 31, 2024 | -31.25% |
| Dec 31, 2023 | 35.71% |
| Sep 30, 2023 | 7.70% |
| Jun 30, 2023 | 60.89% |
| Mar 31, 2023 | -188.65% |
| Dec 31, 2022 | 6.70% |
| Sep 30, 2022 | 63.07% |
| Jun 30, 2022 | -36.58% |
| Mar 31, 2022 | -406.94% |
| Dec 31, 2021 | 156.84% |
| Sep 30, 2021 | -5.40% |
| Jun 30, 2021 | -2.34% |